Editorial introductions : Current Opinion in Pulmonary Medicine

Secondary Logo

Journal Logo


Editorial introductions

Editor(s): Zumla, Alimuddin; Shu-Cheong Hui, David; Bernstein, Jonathan A.

Current Opinion in Pulmonary Medicine 29(3):p v-vii, May 2023. | DOI: 10.1097/MCP.0000000000000960
  • Free

Current Opinion in Pulmonary Medicine was launched in 1995. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of pulmonary medicine is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.


Alimuddin Zumla

Alimuddin Zumla

Sir Professor Alimuddin Zumla Kt., GCDS., MD., PhD., FRCP., FRCPath., FRSB., FAAS., is Professor of Infectious Diseases and International Health in the Division of Infection and Immunity, University College London, UK, and is Consultant Infectious Diseases Physician at University College London Hospitals NHS Foundation Trust. He serves as honorary and visiting Professor at several institutions in Africa, Europe, and the Middle East. Sir Ali is co-Director of PANDORA-ID-NET, a cross-continental ONE-HUMAN-ENVIRONMENTAL-ANIMAL-HEALTH network for taking forward priority research and capacity development to tackle emerging and re-emerging infectious diseases with epidemic potential which threaten global public health security.

Sir Ali is internationally renowned for his outstanding, award-winning, health-policy relevant research, training, capacity development and advocacy outputs on respiratory tract infections, emerging and re-emerging infectious diseases with epidemic potential, antimicrobial resistance and WHO Blueprint priority pathogens. Sir Ali is also internationally distinguished for his pioneering leadership of focusing the international community of the need for moving away from colonial models of research operating in the 1980 s, and establishing equitable, fairer north-south, south-south research partnerships, aligned closely to capacity development and training, based on geographical diversity, gender, ethnic and geographical equity across all continents.

Sir Ali was born in Chipata, Zambia. He is dually qualified in medicine and science. He is an honors graduate (B.Sc.,MB.,ChB.) of the University of Zambia School of Medicine. He gained his MSc degree in clinical Tropical Medicine from the London School of Tropical Medicine and Hygiene (LSH&TM), University of London, UK, for which he obtained a distinction and the Murgatroyd Prize. He obtained his PhD at the LSH&TM UK, for which he was awarded the Alan Woodruff Medal. Whilst working as a medical registrar at the regional infectious disease hospital at Rush Green Hospital, Romford, UK, Sir Ali received international acclaim for rapidly identifying and reporting the first cases of the large 1988 Legionnaires’ Diseases outbreak, which he traced back to BBC Broadcasting House in Central London. Sir Ali then worked for four years as Senior Registrar at the UK's premiere institute, the Hammersmith Hospital, Royal Postgraduate Medical School in London. After obtaining specialist clinical accreditation in infectious diseases and clinical immunology, Sir Ali subsequently spent two years as Associate Professor at the University of Texas Health Science Centre in Houston, Texas, USA, and as visiting Professor at the University Teaching Hospital in Lusaka, Zambia, Africa.

Sir Ali has received over 30 prestigious awards including: the Royal of Physicians Weber Parkes Medal (1999); the World Health Organisation STOP TB Partnership Kochon Prize and Medal (2012); The Times Higher Education Award (2013); the Order of the Grand Commander of Distinguished Services from the President of Zambia (2014); the Albert Chalmers Medal (2000) and the Donald Mackay Medal (2014) from the Royal Society of Tropical Medicine and Hygiene; the UCLHospitals-NHS-Foundation Trust Excellence Award for World Class Research (2015); the Karolinska Institutet, Sweden ’Doctorate honoris causa’ for ‘exceptional contributions to science, healthcare and humanity at large’ (2016); the UK-NIHR Senior Investigator Award (2017); a Knighthood (Knight Bachelor) in June, 2017 from Her Majesty the Queen for exceptional Services to Public Health and Infectious Diseases. Sir Ali was awarded the Union Medal in 2018, the highest honour accorded by the International Union Against TB and Lung Diseases, France; The Mahathir Science Award in 2020, the world's most prestigious Award in theTropical Sciences; The coveted EU-EDCTP Pascoal Mocumbi Award in 2021. In September 2022, The Royal Society of Tropical Medicine and Hygiene (RSTM&H) awarded its most prestigious honour, The Sir Patrick Manson Medal. This made history, since it was the first time in a hundred years that the Manson Medal was awarded to a non-Caucasian Fellow of the RSTM&H!

Sir Ali has over 930 publications and features in the Clarivate 2018, 2019, 2020, 2021 and 2022 lists of the top 1% world's most influential and highly cited researchers. He is Editor of 22 medical textbooks, four of which are globally acknowledged classics: Manson's Tropical Diseases (co-edited with Gordon Cook), Tuberculosis: A Comprehensive Clinical Reference (co-edited with Simon Schaaf), Granulomatous Disorders (co-edited with Geraint James) and Tuberculosis-Perspectives in Medicine (co-edited with Stefan Kaufmann and Eric Ruben). He is senior co-editor (with Ibrahim Abubakar) of the 2021 Handbook of Refugee Health: For Healthcare Professionals and Humanitarians Providing Care to Forced Migrants. Sir Ali has also initiated and led several specialist journal theme series and ‘state of the art’ update reviews on TB, RTIs, Mass Gatherings Medicine, ONE-HEALTH, and AMR involving a global authorship, for continuing medical education and for dissemination the latest literature to health personnel and scientists in low- and middle-income countries.

David Shu-Cheong Hui

David Shu-Cheong Hui

Prof. David Hui, MBBS; MD; FRACP; FRCP; FHKCP; FHKAM is the Director, Stanley Ho Centre for Emerging Infections Diseases and Chairman plus Stanley Ho Professor of Respiratory Medicine, Department of Medicine & Therapeutics at The Chinese University of Hong Kong.

Prof. Hui graduated from the University of New South Wales, Australia, in 1985 and then trained in Respiratory Medicine and Sleep Medicine in Sydney, Australia.

He was heavily involved in the clinical management of patients with SARS at the Prince of Wales Hospital during the major outbreak in 2003. He served as a WHO advisor to review the clinical management of influenza A(H5N1) during the early human outbreak in Vietnam in Feb 2004 and has since been a regular advisor to the WHO on the clinical management of severe acute respiratory infections. He joined urgent WHO missions for investigation of outbreaks of MERS in Riyadh and South Korea in 2013 and 2015 respectively. He has contributed to the WHO treatment guidelines including the clinical management of influenza A (H5N1) virus in 2007, clinical management of influenza A (H1N1) pandemic in 2009, and the Middle East Respiratory Syndrome (MERS) and the WHO training workshop in the clinical management of influenza A(H7N9) and COVID-19. He has been serving as an advisor to the HKSAR government on COVID-19 since Jan 2020.

Dr Hui has published over 360 peer-reviewed journal articles and 24 book chapters since joining the CUHK in 1998. He was the top 1% highly cited researcher (cross fields) in 2021 and 2022 assessed by Clarivate, World's top 2% scientists i in addition to being ranked second and third in respiratory medicine in 2021 and 2022 respectively (Stanford University, Mendeley Data).

His research interests include clinical management of emerging severe acute respiratory infections, the safety of respiratory therapy in the post SARS era, the efficacy of the medical ward airflow in preventing nosocomial infections, sleep disordered breathing, and common airway diseases.

Jonathan A. Bernstein

Jonathan A. Bernstein

Jonathan Bernstein, MD, is Professor of Clinical Medicine in the Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology at the University of Cincinnati Medical Center, USA, a partner of the Bernstein Allergy Group and Clinical Research Center and Editor-In-Chief of the Journal of Asthma. He received his MD from the University of Cincinnati College of Medicine (1981–1985), completed his residency in Internal Medicine at the Cleveland Clinic Hospital (1985–1988) and Allergy/Clinical Immunology training at Northwestern University, USA, (1988–1990). His research interests are related to environmental impact on asthma, chronic urticaria, angioedema, atopic dermatitis, chronic rhinitis subtypes, chronic cough, and women's health issues. He is Secretary Treasurer of the AAAAI and a member of the WAO board of directors, the AAAAI foundation, GINA advocacy council and HAEA organization medical advisory board. Dr Bernstein is the recipient of the AAAAI Distinguished Clinician Award (2019) and the WAO Outstanding Clinician Award (2019). He has authored over 400 peer-reviewed articles and book chapters and is the editor of five books pertaining to asthma, rhinitis and immunodeficiency.

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.